Key result
Custodiol cardioplegia was an independent predictor of an adverse composite outcome compared to cold blood cardioplegia in children undergoing cardiac surgery (OR 3.17; 95% CI 1.41-7.14; P=0.0054).
Why the study?
Does Custodiol cardioplegia reduce adverse outcomes compared to cold blood cardioplegia in children undergoing cardiac surgery?
Cohort (n=154)
Yes
Does Custodiol cardioplegia reduce adverse outcomes compared to cold blood cardioplegia in children undergoing cardiac surgery?
Odds Ratio: 3.17 (95% CI 1.41–7.14)
p-value: p=0.0054
In pediatric cardiac surgery, the use of Custodiol cardioplegia is associated with a significantly higher risk of adverse outcomes, including death, low cardiac output syndrome, AKI, and arrhythmias, compared to cold blood cardioplegia.
May warrant caution with Custodiol in pediatric cardiac surgery; hypothesis-generating observational data requiring RCT confirmation.
Background Cold blood cardioplegia is widely used as a method of myocardial protection in pediatric cardiac surgery. Operative interruption to administer cardioplegia and need for repeated administration and occasional direct coronary ostial cannulation are considered a drawbacks of this technique. Custodiol, a crystalloid solution, has been used in children as an alternative cardioplegia solution with the potential advantage of single dose administration with equivalent myocardial protection. We sought to compare the outcomes of cold blood cardioplegia versus Custodiol cardioplegia in pediatric cardiac surgery. Methods A retrospective cohort study was performed between November 1st, 2013 and June 30th, 2014. All children who underwent heart surgery at two institutions with the use of cardiopulmonary bypass and cardioplegia were included. Patients were identified from a prospective database and additional data were collected from operative report and electronic and paper charts. Continuous data were represented as median and interquartile range, and tested with Wilcoxon rank-sum test. Categorical data were represented as proportions, and tested with Pearson test. A composite endpoint of all cause death, Low Cardiac Output Syndrome (LCOS), Acute Kidney Injury (AKI), and significant arrhythmia was analyzed with a multiple logistic regression model adjusted for complexity using the Risk Adjustment of Congenital Heart Surgery -1 (RACHS-1) categories. A p-value of less than 0.05 was considered to be significant. Results Blood cardioplegia was administered in 88 (57.1%) patients, and Custodiol cardioplegia was administered in 66 (42.9%) patients according to surgeon's preference. In the risk adjusted comparison of the composite outcome of all-cause death, LCOS, AKI and significant arrhythmia, Custodiol cardioplegia was found to be an independent predictor of an adverse outcome, OR 3.17 (95% CI 1.41–7.14, P-value = 0.0054). Conclusions Custodial cardioplegia is associated with less optimal myocardial protection and higher adverse outcomes compared to cold blood cardioplegia in children undergoing cardiac surgery. A randomized comparison is warranted.
No takes yet. Share an insight, caveat, or question.
Qulisy et al. (2016) conducted a cohort in pediatric cardiac surgery (n=154). Custodiol cardioplegia vs. Cold blood cardioplegia was evaluated on Composite outcome of all-cause death, Low Cardiac Output Syndrome (LCOS), Acute Kidney Injury (AKI), and significant arrhythmia (OR 3.17, 95% CI 1.41-7.14, p=0.0054). Custodiol cardioplegia was an independent predictor of an adverse composite outcome compared to cold blood cardioplegia in children undergoing cardiac surgery (OR 3.17; 95% CI 1.41-7.14; P=0.0054).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: